Fluctuation of intratumor biological variables as a function of menstrual timing of surgery for breast cancer in premenopausal patients [5]

Annals of Oncology

Volumn 14, Issue 6, 2003, Pages 962-964

  Coradini, Danila ^a   Veneroni, S ^a   Pellizzaro, C ^a   Daidone, M G ^a  

^a Isto Nazl Studio/Cura dei Tumori ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR;

BREAST CANCER; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE ACTIVITY; ESTRADIOL BLOOD LEVEL; HUMAN; LETTER; LUTEAL PHASE; MENSTRUAL CYCLE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT PLANNING;

ANGIOGENESIS INDUCING AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; FEMALE; HUMANS; MENSTRUAL CYCLE; PREMENOPAUSE; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038011611     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg245     Document Type: Letter

References (5)

1. Fentiman IS. Timing of surgery for breast cancer. Int J Clin Pract 2002; 56: 188-190.
2. Love RR, Duc NB, Dinh NV et al. Mastectomy and oophrectomy by menstrual cycle phase in women with operable breast cancer. J Natl Cancer Inst 2002; 94: 662-669.
3. Saad Z, Bramwell VH, Wilson SM et al. Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases. Lancet 1998; 351: 1170-1173.
4. Balsari A, Casalini P, Tagliabue E et al. Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle. Am J Pathol 1999; 155: 1543-1547.
5. Heer K, Kumar H, Speirs V et al. Vascular endothelial growth factor in premenopausal women - indicator of the best time for breast cancer surgery? Br J Cancer 1998; 78: 1203-1207.